Biology:Lymphoid enhancer-binding factor 1

From HandWiki
Short description: Protein-coding gene in the species Homo sapiens


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example


Lymphoid enhancer-binding factor 1 (LEF1) is a protein that in humans is encoded by the LEF1 gene.[1] It is a member of T cell factor/lymphoid enhancer factor (TCF/LEF) family.

Function

Lymphoid enhancer-binding factor-1 (LEF1) is a 48-kD nuclear protein that is expressed in pre-B and T cells. It binds to a functionally important site in the T-cell receptor-alpha (TCRA) enhancer and confers maximal enhancer activity. LEF1 belongs to a family of regulatory proteins that share homology with high mobility group protein-1 (HMG1).[2]

Clinical significance

LEF1 is highly overexpressed and associated with disease progression and poor prognosis in B-cell chronic lymphocytic leukemia[3] and other kinds of malignancies like colorectal cancer.[4] It is also a promising potential drug target.[5]

Interactions

Lymphoid enhancer-binding factor 1 has been shown to interact with:

References

  1. "Gene for lymphoid enhancer-binding factor 1 (LEF1) mapped to human chromosome 4 (q23-q25) and mouse chromosome 3 near Egf". Genomics 11 (4): 1040–1048. December 1991. doi:10.1016/0888-7543(91)90030-I. PMID 1783375. 
  2. "Entrez Gene: LEF1 lymphoid enhancer-binding factor 1". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=51176. 
  3. "High lymphoid enhancer-binding factor-1 expression is associated with disease progression and poor prognosis in chronic lymphocytic leukemia". Hematology Reports 2 (1): e3. January 2010. doi:10.4081/hr.2010.e3. PMID 22184516. 
  4. "An integrated study on TFs and miRNAs in colorectal cancer metastasis and evaluation of three co-regulated candidate genes as prognostic markers". Gene 679: 150–159. December 2018. doi:10.1016/j.gene.2018.09.003. PMID 30193961. 
  5. "Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo". Neoplasia 12 (4): 326–335. April 2010. doi:10.1593/neo.91972. PMID 20360943. 
  6. "Alx4 binding to LEF-1 regulates N-CAM promoter activity". The Journal of Biological Chemistry 277 (2): 1120–1127. January 2002. doi:10.1074/jbc.M109912200. PMID 11696550. 
  7. "A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia". The Journal of Biological Chemistry 275 (1): 651–656. January 2000. doi:10.1074/jbc.275.1.651. PMID 10617663. 
  8. "Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis". Molecular and Cellular Biology 25 (4): 1475–1488. February 2005. doi:10.1128/MCB.25.4.1475-1488.2005. PMID 15684397. 
  9. "A functional screen in human cells identifies UBF2 as an RNA polymerase II transcription factor that enhances the beta-catenin signaling pathway". Molecular and Cellular Biology 23 (11): 3936–3950. June 2003. doi:10.1128/MCB.23.11.3936-3950.2003. PMID 12748295. 
  10. "Functional interaction of beta-catenin with the transcription factor LEF-1". Nature 382 (6592): 638–642. August 1996. doi:10.1038/382638a0. PMID 8757136. Bibcode1996Natur.382..638B. 
  11. 11.0 11.1 11.2 "Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways". Proceedings of the National Academy of Sciences of the United States of America 97 (15): 8358–8363. July 2000. doi:10.1073/pnas.150152697. PMID 10890911. Bibcode2000PNAS...97.8358L. 
  12. "Three habits of highly effective signaling pathways: principles of transcriptional control by developmental cell signaling". Genes & Development (Cold Spring Harbor Laboratory Press & The Genetics Society) 16 (10): 1167–1181. May 2002. doi:10.1101/gad.976502. PMID 12023297. "In ... zebrafish, reporter transgenes containing the TOPFLASH promoter are expressed in certain Wnt-responsive cell types (...Dorsky et al. 2002).". 
  13. "Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4". The Journal of Biological Chemistry 278 (6): 3776–3785. February 2003. doi:10.1074/jbc.M210081200. PMID 12446687. 
  14. "Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling". The EMBO Journal 21 (11): 2703–2714. June 2002. doi:10.1093/emboj/21.11.2703. PMID 12032083. 
  15. "PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies". Genes & Development 15 (23): 3088–3103. December 2001. doi:10.1101/gad.944801. PMID 11731474. 

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.